Riskpilot← Back to searchSign inGet full accessBioMensio Oy
OYBankruptY-tunnus 2726684-5Hermiankatu 68-HManufacture of instruments and appliances for measuring, testing and navigation · NACE 2651Est. 2015— employeeswww.biomensio.com
Revenue 2023
EUR 87K
+294% vs 2022
EBITDA margin
-851.6%
+15% vs 2022
Equity ratio
89.3%
Financial strength
Net profit 2023
EUR -1,4M
+12% vs 2022
| Revenue | EUR 87K | +294% |
| EBITDA | EUR -737K | +15% |
| Net profit | EUR -1,4M | +12% |
| Total assets | EUR 7,5M | -18% |
| Equity | EUR 6,7M | -18% |
| Employees | — | — |
Legal name
BioMensio Oy
Y-tunnus number
2726684-5
Legal form
Osakeyhtiö
NACE code
2651 · Manufacture of instruments and appliances for measuring, testing and navigation
Founded
24. marraskuuta 2015
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääketieteen, biotekniikan ja kemian alan diagnostiikka- ja tutkimuslaitteiden ja -menetelmien ja -lisenssien valmistus, vienti, tuonti, välitys sekä alan koulutus, konsultointi sekä kehitys- ja tutkimustyö. Lisäksi yhtiö voi omistaa ja hallita kiinteää omaisuutta ja arvopapereita sekä käydä niillä kauppaa.
Address
Hermiankatu 68-H
Email
info@biomensio.com
Website
www.biomensio.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 25 | 20 | 22 | 87 |
| Staff expenses | −711 | −735 | −840 | −970 | −1 168 |
| EBITDA | −491 | −413 | −693 | −872 | −737 |
| Depreciation & amort. | −176 | −201 | −331 | −544 | −735 |
| EBIT | −667 | −614 | −1 024 | −1 416 | −1 471 |
| Net financials | −4 | −11 | −408 | −226 | 26 |
| Profit before tax | −672 | −625 | −1 432 | −1 642 | −1 445 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −672 | −625 | −1 432 | −1 642 | −1 445 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 1 543 | 1 394 | 7 219 | 9 210 | 7 527 |
| Equity | 819 | 193 | 6 507 | 8 166 | 6 720 |
| Long-term debt | 203 | 269 | 209 | 279 | 212 |
| Short-term debt | 522 | 932 | 504 | 765 | 595 |
| Total debt | 724 | 1 201 | 712 | 1 044 | 807 |
EBITDA margin
-851.6%
This company
15.8%
Market median
-5490% vs market
20192023
Equity ratio
89.3%
This company
38.2%
Market median
+134% vs market
20192023
Return on equity
-21.5%
This company
18.4%
Market median
-217% vs market
20192023
Net profit margin
-1670.3%
This company
8.1%
Market median
-20721% vs market
20192023
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20192023
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20192023
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HE Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (5) | ||
AJ Chief Executive Officer | Chief Executive Officer | 2019 – 2020 |
NT Audit | Audit | 2020 – 2022 |
| Audit | 2022 – 2023 | |
JA | Audit | 2016 – 2020 |
KI Chief Executive Officer | Chief Executive Officer | 2016 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairperson | 2018 | |
| Board of Directors | 2023 | |
| Former (3) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2018 – 2023 | |
| Board of Directors | 2019 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BioMensio Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Harri Ensio Leinonen | Chief Executive Officer | 0 companies |
| Antti Johannes Sinisalo | Chief Executive Officer | 0 companies |
| Niko Tuomas Huusko | Audit | 0 companies |
| Aleksi Jaakko Johannes Riikonen | Audit | 0 companies |
| Janne Antero Rajalahti | Audit | 0 companies |
| Kari Ilari Antila | Chief Executive Officer | 0 companies |
| John Charles Morrison | Board of Directors | 0 companies |
| Jussi Tapio Sainiemi | Board of Directors | 0 companies |
| Stephan Buchholz | Board of Directors | 0 companies |
| Jenny Maria Engerfelt | Board of Directors | 0 companies |
| Sauli Juhani Törmälä | Chairperson | 0 companies |
| Georg Karl Hermann Bodammer | Board of Directors | 0 companies |
| Mikko Väinö Mikael Kumpulainen | Board of Directors | 0 companies |